HEADER TRANSFERASE 13-JAN-20 6TX3 TITLE HPF1 BOUND TO CATALYTIC FRAGMENT OF PARP2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 2,POLY [ADP-RIBOSE] POLYMERASE COMPND 3 2; COMPND 4 CHAIN: B; COMPND 5 SYNONYM: HPARP-2,ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 2, COMPND 6 ARTD2,DNA ADP-RIBOSYLTRANSFERASE PARP2,NAD(+) ADP-RIBOSYLTRANSFERASE COMPND 7 2,ADPRT-2,POLY[ADP-RIBOSE] SYNTHASE 2,PADPRT-2,PROTEIN POLY-ADP- COMPND 8 RIBOSYLTRANSFERASE PARP2,HPARP-2,ADP-RIBOSYLTRANSFERASE DIPHTHERIA COMPND 9 TOXIN-LIKE 2,ARTD2,DNA ADP-RIBOSYLTRANSFERASE PARP2,NAD(+) ADP- COMPND 10 RIBOSYLTRANSFERASE 2,ADPRT-2,POLY[ADP-RIBOSE] SYNTHASE 2,PADPRT-2, COMPND 11 PROTEIN POLY-ADP-RIBOSYLTRANSFERASE PARP2; COMPND 12 EC: 2.4.2.30,2.4.2.-,2.4.2.30,2.4.2.-; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 2; COMPND 15 MOLECULE: HISTONE PARYLATION FACTOR 1; COMPND 16 CHAIN: A; COMPND 17 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP2, ADPRT2, ADPRTL2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: ROSETTA; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 GENE: HPF1, C4ORF27; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 16 EXPRESSION_SYSTEM_VARIANT: ROSETTA KEYWDS PARP2, ARTD2, ADP-RIBOSYLATION, SERINE ADP-RIBOSYLATION, HPF1, KEYWDS 2 C4ORF27, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.J.SUSKIEWICZ,I.AHEL REVDAT 3 01-MAY-24 6TX3 1 REMARK REVDAT 2 08-APR-20 6TX3 1 JRNL REVDAT 1 19-FEB-20 6TX3 0 JRNL AUTH M.J.SUSKIEWICZ,F.ZOBEL,T.E.H.OGDEN,P.FONTANA,A.ARIZA, JRNL AUTH 2 J.C.YANG,K.ZHU,L.BRACKEN,W.J.HAWTHORNE,D.AHEL,D.NEUHAUS, JRNL AUTH 3 I.AHEL JRNL TITL HPF1 COMPLETES THE PARP ACTIVE SITE FOR DNA DAMAGE-INDUCED JRNL TITL 2 ADP-RIBOSYLATION. JRNL REF NATURE V. 579 598 2020 JRNL REFN ESSN 1476-4687 JRNL PMID 32028527 JRNL DOI 10.1038/S41586-020-2013-6 REMARK 2 REMARK 2 RESOLUTION. 2.96 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_3126 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.96 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.28 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 22155 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.231 REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.730 REMARK 3 FREE R VALUE TEST SET COUNT : 1048 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.2750 - 5.6597 1.00 3119 171 0.1887 0.2061 REMARK 3 2 5.6597 - 4.4934 1.00 3093 136 0.2187 0.2652 REMARK 3 3 4.4934 - 3.9257 0.99 3023 176 0.2190 0.2669 REMARK 3 4 3.9257 - 3.5669 0.97 2991 153 0.2574 0.3200 REMARK 3 5 3.5669 - 3.3113 0.96 2995 101 0.3118 0.4021 REMARK 3 6 3.3113 - 3.1162 0.96 2931 162 0.3988 0.4449 REMARK 3 7 3.1162 - 2.9601 0.96 2955 149 0.4961 0.5139 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.480 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 45.360 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 154.0 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6TX3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-JAN-20. REMARK 100 THE DEPOSITION ID IS D_1292105942. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JUL-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9762 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 XE 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : XIA2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45403 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.960 REMARK 200 RESOLUTION RANGE LOW (A) : 100.130 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 10.41 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.96 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 10.77 REMARK 200 R MERGE FOR SHELL (I) : 1.20000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: APO HUMAN HPF1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MES PH 6, 25% V/V REMARK 280 PENTAERYTHRITOL PROPOXYLATE (5/4 PO/OH), VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.86900 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 95.73800 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 71.80350 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 119.67250 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 23.93450 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2660 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25100 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET B 197 REMARK 465 GLY B 198 REMARK 465 SER B 199 REMARK 465 SER B 200 REMARK 465 HIS B 201 REMARK 465 HIS B 202 REMARK 465 HIS B 203 REMARK 465 HIS B 204 REMARK 465 HIS B 205 REMARK 465 HIS B 206 REMARK 465 SER B 207 REMARK 465 SER B 208 REMARK 465 GLY B 209 REMARK 465 LEU B 210 REMARK 465 VAL B 211 REMARK 465 PRO B 212 REMARK 465 ARG B 213 REMARK 465 GLY B 214 REMARK 465 SER B 215 REMARK 465 HIS B 216 REMARK 465 VAL B 329 REMARK 465 GLN B 330 REMARK 465 ALA B 331 REMARK 465 MET B 332 REMARK 465 GLU B 333 REMARK 465 GLU B 334 REMARK 465 LYS B 335 REMARK 465 THR B 336 REMARK 465 GLU B 337 REMARK 465 LEU B 338 REMARK 465 GLN B 339 REMARK 465 MET A 29 REMARK 465 GLY A 30 REMARK 465 HIS A 31 REMARK 465 HIS A 32 REMARK 465 HIS A 33 REMARK 465 HIS A 34 REMARK 465 LYS A 95 REMARK 465 LYS A 96 REMARK 465 SER A 97 REMARK 465 THR A 98 REMARK 465 ALA A 345 REMARK 465 ALA A 346 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS B 361 -7.68 -58.76 REMARK 500 HIS B 381 56.86 -106.52 REMARK 500 GLU B 436 -139.79 -81.44 REMARK 500 ILE B 439 -113.78 78.18 REMARK 500 ASN B 489 103.12 -161.65 REMARK 500 ARG B 557 -42.58 -130.35 REMARK 500 LYS A 92 72.82 -111.80 REMARK 500 THR A 93 -51.53 -137.89 REMARK 500 ASN A 157 55.38 -147.58 REMARK 500 THR A 221 176.29 64.66 REMARK 500 ARG A 322 55.05 -112.82 REMARK 500 ASN A 340 17.88 -146.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue UHB B 1001 DBREF 6TX3 B 217 334 UNP Q9UGN5 PARP2_HUMAN 230 253 DBREF 6TX3 B 335 570 UNP Q9UGN5 PARP2_HUMAN 348 583 DBREF 6TX3 A 37 346 UNP Q9NWY4 HPF1_HUMAN 37 346 SEQADV 6TX3 MET B 197 UNP Q9UGN5 INITIATING METHIONINE SEQADV 6TX3 GLY B 198 UNP Q9UGN5 EXPRESSION TAG SEQADV 6TX3 SER B 199 UNP Q9UGN5 EXPRESSION TAG SEQADV 6TX3 SER B 200 UNP Q9UGN5 EXPRESSION TAG SEQADV 6TX3 HIS B 201 UNP Q9UGN5 EXPRESSION TAG SEQADV 6TX3 HIS B 202 UNP Q9UGN5 EXPRESSION TAG SEQADV 6TX3 HIS B 203 UNP Q9UGN5 EXPRESSION TAG SEQADV 6TX3 HIS B 204 UNP Q9UGN5 EXPRESSION TAG SEQADV 6TX3 HIS B 205 UNP Q9UGN5 EXPRESSION TAG SEQADV 6TX3 HIS B 206 UNP Q9UGN5 EXPRESSION TAG SEQADV 6TX3 SER B 207 UNP Q9UGN5 EXPRESSION TAG SEQADV 6TX3 SER B 208 UNP Q9UGN5 EXPRESSION TAG SEQADV 6TX3 GLY B 209 UNP Q9UGN5 EXPRESSION TAG SEQADV 6TX3 LEU B 210 UNP Q9UGN5 EXPRESSION TAG SEQADV 6TX3 VAL B 211 UNP Q9UGN5 EXPRESSION TAG SEQADV 6TX3 PRO B 212 UNP Q9UGN5 EXPRESSION TAG SEQADV 6TX3 ARG B 213 UNP Q9UGN5 EXPRESSION TAG SEQADV 6TX3 GLY B 214 UNP Q9UGN5 EXPRESSION TAG SEQADV 6TX3 SER B 215 UNP Q9UGN5 EXPRESSION TAG SEQADV 6TX3 HIS B 216 UNP Q9UGN5 EXPRESSION TAG SEQADV 6TX3 MET A 29 UNP Q9NWY4 INITIATING METHIONINE SEQADV 6TX3 GLY A 30 UNP Q9NWY4 EXPRESSION TAG SEQADV 6TX3 HIS A 31 UNP Q9NWY4 EXPRESSION TAG SEQADV 6TX3 HIS A 32 UNP Q9NWY4 EXPRESSION TAG SEQADV 6TX3 HIS A 33 UNP Q9NWY4 EXPRESSION TAG SEQADV 6TX3 HIS A 34 UNP Q9NWY4 EXPRESSION TAG SEQADV 6TX3 HIS A 35 UNP Q9NWY4 EXPRESSION TAG SEQADV 6TX3 HIS A 36 UNP Q9NWY4 EXPRESSION TAG SEQADV 6TX3 LYS A 174 UNP Q9NWY4 ARG 174 VARIANT SEQRES 1 B 280 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 280 LEU VAL PRO ARG GLY SER HIS PRO GLU SER GLN LEU ASP SEQRES 3 B 280 LEU ARG VAL GLN GLU LEU ILE LYS LEU ILE CYS ASN VAL SEQRES 4 B 280 GLN ALA MET GLU GLU LYS THR GLU LEU GLN SER PRO GLU SEQRES 5 B 280 HIS PRO LEU ASP GLN HIS TYR ARG ASN LEU HIS CYS ALA SEQRES 6 B 280 LEU ARG PRO LEU ASP HIS GLU SER TYR GLU PHE LYS VAL SEQRES 7 B 280 ILE SER GLN TYR LEU GLN SER THR HIS ALA PRO THR HIS SEQRES 8 B 280 SER ASP TYR THR MET THR LEU LEU ASP LEU PHE GLU VAL SEQRES 9 B 280 GLU LYS ASP GLY GLU LYS GLU ALA PHE ARG GLU ASP LEU SEQRES 10 B 280 HIS ASN ARG MET LEU LEU TRP HIS GLY SER ARG MET SER SEQRES 11 B 280 ASN TRP VAL GLY ILE LEU SER HIS GLY LEU ARG ILE ALA SEQRES 12 B 280 PRO PRO GLU ALA PRO ILE THR GLY TYR MET PHE GLY LYS SEQRES 13 B 280 GLY ILE TYR PHE ALA ASP MET SER SER LYS SER ALA ASN SEQRES 14 B 280 TYR CYS PHE ALA SER ARG LEU LYS ASN THR GLY LEU LEU SEQRES 15 B 280 LEU LEU SER GLU VAL ALA LEU GLY GLN CYS ASN GLU LEU SEQRES 16 B 280 LEU GLU ALA ASN PRO LYS ALA GLU GLY LEU LEU GLN GLY SEQRES 17 B 280 LYS HIS SER THR LYS GLY LEU GLY LYS MET ALA PRO SER SEQRES 18 B 280 SER ALA HIS PHE VAL THR LEU ASN GLY SER THR VAL PRO SEQRES 19 B 280 LEU GLY PRO ALA SER ASP THR GLY ILE LEU ASN PRO ASP SEQRES 20 B 280 GLY TYR THR LEU ASN TYR ASN GLU TYR ILE VAL TYR ASN SEQRES 21 B 280 PRO ASN GLN VAL ARG MET ARG TYR LEU LEU LYS VAL GLN SEQRES 22 B 280 PHE ASN PHE LEU GLN LEU TRP SEQRES 1 A 318 MET GLY HIS HIS HIS HIS HIS HIS LEU ARG LYS GLU VAL SEQRES 2 A 318 GLU ASN HIS TYR LYS LEU SER LEU PRO GLU ASP PHE TYR SEQRES 3 A 318 HIS PHE TRP LYS PHE CYS GLU GLU LEU ASP PRO GLU LYS SEQRES 4 A 318 PRO SER ASP SER LEU SER ALA SER LEU GLY LEU GLN LEU SEQRES 5 A 318 VAL GLY PRO TYR ASP ILE LEU ALA GLY LYS HIS LYS THR SEQRES 6 A 318 LYS LYS LYS SER THR GLY LEU ASN PHE ASN LEU HIS TRP SEQRES 7 A 318 ARG PHE TYR TYR ASP PRO PRO GLU PHE GLN THR ILE ILE SEQRES 8 A 318 ILE GLY ASP ASN LYS THR GLN TYR HIS MET GLY TYR PHE SEQRES 9 A 318 ARG ASP SER PRO ASP GLU PHE PRO VAL TYR VAL GLY ILE SEQRES 10 A 318 ASN GLU ALA LYS LYS ASN CYS ILE ILE VAL PRO ASN GLY SEQRES 11 A 318 ASP ASN VAL PHE ALA ALA VAL LYS LEU PHE LEU THR LYS SEQRES 12 A 318 LYS LEU LYS GLU ILE THR ASP LYS LYS LYS ILE ASN LEU SEQRES 13 A 318 LEU LYS ASN ILE ASP GLU LYS LEU THR GLU ALA ALA ARG SEQRES 14 A 318 GLU LEU GLY TYR SER LEU GLU GLN ARG THR VAL LYS MET SEQRES 15 A 318 LYS GLN ARG ASP LYS LYS VAL VAL THR LYS THR PHE HIS SEQRES 16 A 318 GLY ALA GLY LEU VAL VAL PRO VAL ASP LYS ASN ASP VAL SEQRES 17 A 318 GLY TYR ARG GLU LEU PRO GLU THR ASP ALA ASP LEU LYS SEQRES 18 A 318 ARG ILE CYS LYS THR ILE VAL GLU ALA ALA SER ASP GLU SEQRES 19 A 318 GLU ARG LEU LYS ALA PHE ALA PRO ILE GLN GLU MET MET SEQRES 20 A 318 THR PHE VAL GLN PHE ALA ASN ASP GLU CYS ASP TYR GLY SEQRES 21 A 318 MET GLY LEU GLU LEU GLY MET ASP LEU PHE CYS TYR GLY SEQRES 22 A 318 SER HIS TYR PHE HIS LYS VAL ALA GLY GLN LEU LEU PRO SEQRES 23 A 318 LEU ALA TYR ASN LEU LEU LYS ARG ASN LEU PHE ALA GLU SEQRES 24 A 318 ILE ILE GLU GLU HIS LEU ALA ASN ARG SER GLN GLU ASN SEQRES 25 A 318 ILE ASP GLN LEU ALA ALA HET UHB B1001 39 HETNAM UHB 2-[4-[(2S,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4- HETNAM 2 UHB BIS(OXIDANYL)OXOLAN-2-YL]CARBONYLPIPERAZIN-1-YL]-N-(1- HETNAM 3 UHB OXIDANYLIDENE-2,3-DIHYDROISOINDOL-4-YL)ETHANAMIDE FORMUL 3 UHB C24 H27 N9 O6 HELIX 1 AA1 ASP B 222 CYS B 233 1 12 HELIX 2 AA2 HIS B 343 ARG B 350 1 8 HELIX 3 AA3 SER B 363 THR B 376 1 14 HELIX 4 AA4 GLY B 398 PHE B 403 1 6 HELIX 5 AA5 ARG B 418 SER B 420 5 3 HELIX 6 AA6 ASN B 421 GLY B 429 1 9 HELIX 7 AA7 MET B 453 ASN B 459 1 7 HELIX 8 AA8 TYR B 460 PHE B 462 5 3 HELIX 9 AA9 GLU B 493 GLN B 497 5 5 HELIX 10 AB1 SER B 512 PHE B 515 5 4 HELIX 11 AB2 ASN B 550 ASN B 552 5 3 HELIX 12 AB3 LEU A 37 LYS A 46 1 10 HELIX 13 AB4 PRO A 50 ASP A 64 1 15 HELIX 14 AB5 LYS A 67 SER A 71 5 5 HELIX 15 AB6 LEU A 72 GLY A 77 1 6 HELIX 16 AB7 GLY A 82 ALA A 88 1 7 HELIX 17 AB8 ASN A 160 LYS A 174 1 15 HELIX 18 AB9 ASP A 178 GLY A 200 1 23 HELIX 19 AC1 THR A 207 LYS A 215 1 9 HELIX 20 AC2 THR A 244 GLU A 257 1 14 HELIX 21 AC3 SER A 260 PHE A 268 1 9 HELIX 22 AC4 PHE A 268 GLU A 284 1 17 HELIX 23 AC5 TYR A 287 GLY A 301 1 15 HELIX 24 AC6 SER A 302 TYR A 304 5 3 HELIX 25 AC7 PHE A 305 LEU A 320 1 16 HELIX 26 AC8 ARG A 322 ASN A 335 1 14 SHEET 1 AA1 5 CYS B 354 PRO B 358 0 SHEET 2 AA1 5 TYR B 384 LYS B 396 -1 O GLU B 393 N ARG B 357 SHEET 3 AA1 5 VAL B 554 PHE B 566 -1 O LYS B 561 N ASP B 390 SHEET 4 AA1 5 THR B 469 ALA B 478 -1 N LEU B 472 O LEU B 560 SHEET 5 AA1 5 ARG B 410 GLY B 416 -1 N LEU B 413 O SER B 475 SHEET 1 AA2 4 ILE B 448 PHE B 450 0 SHEET 2 AA2 4 GLU B 545 VAL B 548 -1 O VAL B 548 N ILE B 448 SHEET 3 AA2 4 SER B 501 GLY B 504 -1 N THR B 502 O ILE B 547 SHEET 4 AA2 4 CYS B 482 LEU B 485 1 N ASN B 483 O SER B 501 SHEET 1 AA3 2 MET B 508 PRO B 510 0 SHEET 2 AA3 2 ALA B 528 ASP B 530 -1 O SER B 529 N ALA B 509 SHEET 1 AA4 2 VAL B 516 LEU B 518 0 SHEET 2 AA4 2 SER B 521 VAL B 523 -1 O VAL B 523 N VAL B 516 SHEET 1 AA5 5 GLN A 79 LEU A 80 0 SHEET 2 AA5 5 PHE A 115 ILE A 120 -1 O ILE A 120 N GLN A 79 SHEET 3 AA5 5 TYR A 127 PHE A 132 -1 O MET A 129 N ILE A 119 SHEET 4 AA5 5 TYR A 142 GLU A 147 -1 O GLY A 144 N GLY A 130 SHEET 5 AA5 5 VAL A 155 PRO A 156 -1 O VAL A 155 N ILE A 145 CISPEP 1 GLY B 526 PRO B 527 0 5.89 SITE 1 AC1 14 HIS B 415 GLY B 416 SER B 417 ASN B 421 SITE 2 AC1 14 GLY B 424 ILE B 425 GLY B 429 ARG B 431 SITE 3 AC1 14 PRO B 434 TYR B 442 TYR B 449 SER B 457 SITE 4 AC1 14 TYR B 460 GLU B 545 CRYST1 115.622 115.622 143.607 90.00 90.00 120.00 P 61 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008649 0.004993 0.000000 0.00000 SCALE2 0.000000 0.009987 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006963 0.00000